Celltrion, Inc.

Incheon, Incheon, South Korea celltrion.com

Overview

Celltrion, Inc. is a South Korean biopharmaceutical company specializing in the development, production, and commercialization of biosimilars and innovative biologics. It is known for its pioneering efforts in the monoclonal antibody sector, offering treatments in various therapeutic areas.

Therapeutic areas

OncologyAutoimmune DiseasesInfectious Diseases

FDA compliance signals

2 FDA enforcement records linked to this company.

  • 4832019-10-22

    Air Supply

  • warning_letter2018-01-29

    FDA Warning Letter (drug product)

Related companies

NKMAX Bio, Inc.
South Korea
Biocad
Russia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
China
ImmuniTherapeutics Inc.
USA
Immunocore Holdings Plc
United Kingdom
Immunowake Inc.
United States
Jubilant HollisterStier LLC
United States
ModernaTX, Inc.
USA

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo